AB012. Limited assessment of patient-reported outcomes in clinical trials of thymic epithelial tumors despite the relevance of safety findings: a systematic review
Mediastinum · 2026-10 · 10 · AB012-AB012
DOI: 10.21037/med-26-ab012 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Mediastinum, 2026-10. Verfasst von Erica Pietroluongo und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pietroluongo, E., Salomone, F., Ferrara, R., Guerrera, F., Marcuse, F., Lehmann, J., Husson, O., Leite, M. I., Girard, N., & Pompili, C. (2026). AB012. Limited assessment of patient-reported outcomes in clinical trials of thymic epithelial tumors despite the relevance of safety findings: a systematic review. Mediastinum, 10, AB012-AB012. https://doi.org/10.21037/med-26-ab012
Vancouver
Pietroluongo E, Salomone F, Ferrara R, Guerrera F, Marcuse F, Lehmann J, et al. AB012. Limited assessment of patient-reported outcomes in clinical trials of thymic epithelial tumors despite the relevance of safety findings: a systematic review. Mediastinum. 2026;10:AB012-AB012. doi:10.21037/med-26-ab012
BibTeX
@article{Pietroluongo2026,
author = {Pietroluongo, Erica and Salomone, Fabio and Ferrara, Roberto and Guerrera, Francesco and Marcuse, Florit and Lehmann, Jens and Husson, Olga and Leite, Maria Isabel and Girard, Nicolas and Pompili, Cecilia},
title = {AB012. Limited assessment of patient-reported outcomes in clinical trials of thymic epithelial tumors despite the relevance of safety findings: a systematic review},
journal = {Mediastinum},
year = {2026},
volume = {10},
pages = {AB012--AB012},
doi = {10.21037/med-26-ab012}
}
EUVIMED